India Approves Further Trials For First Homegrown MRNA Covid-19 Vaccine
[email protected]27 Sep, 2021News
India on Tuesday (Aug 24) approved further clinical trials for its first homegrown mRNA-based Covid-19 vaccine, being developed by Gennova Biopharmaceuticals, after the shot was found to be safe and effective in an early-stage study. The country has authorised emergency use for two domestically developed Covid-19 vaccines, made by Bharat Biotech and Zydus Cadila, but does not have mRNA-based vaccines yet in its immunisation programme ahead of a potential third coronavirus wave.
Related Bookmarks
- India's First MRNA COVID-19 Vaccine Candidate Approved To Start Phase II, III Trials
- Wrist Mala Bracelets
- India�s First MRNA-Based COVID-19 Vaccine Gets DCGI Nod To Move Into Ph-2 & Ph-3 Trial
- Riyadh Season 2021 coming to a desert near you | Arab News
- Fix: Modern Warfare DirectX Encountered Unrecoverable Error on Windows 10
- Learn The Basics About Greek Squad
- Buy Stainless Steel Dome Cup and Saucer Tea Set Online
- How to Customize the AirPods Pro Controls?
- UK PM urged to come to aid of Afghan girls� football team
- Community Service Near Me |planowestrotary.com
Recent Profiles
Wolfe Moving Systems
2gospa
Rustic Wall Sconces
Canadian Cpap Equipment
Aadvik Foods
Nohu
Fabulousjuwa
High Heels
Dengue Test At Home
Al Fresco Wedding